Stroke. 1997 Aug;28(8):1530-40. doi: 10.1161/01.str.28.8.1530.
With the approval by the Food and Drug Administration of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke within 180 minutes of symptom onset, patients and prehospital and hospital systems will now have to treat stroke as a medical emergency. It is thus critical to develop efficient hospital-based methods for hyperacute stroke patient evaluation and intervention at both community-based and tertiary care academic centers.
We describe how the eight centers in the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial developed systems for enrolling patients within 3 hours of symptom onset. The actual methodology and practical sequence of events are detailed. Deming principles of system organization were applied, and each center developed a flowchart of acute stroke patient screening, assessment, and treatment. We divided the process into the following: clinical center background and preparation, screening, stroke team response, data needed before treatment, CT of the head, pharmacy, patient treatment, and monitored care. Critical features, both unique to a given center and shared by several centers (common at four or more centers), were summarized.
Phase I of the trial included several months of preparation with review of every detail involved in the process of acute stroke care at each site. All centers worked closely with emergency medical services. Community stroke awareness and education programs were developed. A stroke team was initiated and worked closely with the emergency department physicians and nurses. Rapid and efficient communication systems and protocols were established to reduce time to complete each task. Standardized stroke examinations and protocols for blood pressure management and intracranial hemorrhage detection as well as nursing flowcharts were used.
Hyperacute stroke treatment can be initiated, often within 55 minutes of patient arrival at the hospital, in both community and academic settings when all aspects of stroke care processes are identified, streamlined, and built into the day-to-day operations of the prehospital and hospital healthcare delivery system.
随着美国食品药品监督管理局批准重组组织型纤溶酶原激活剂(rt-PA)用于症状发作180分钟内的急性缺血性卒中治疗,患者以及院前和医院系统现在必须将卒中作为医疗紧急情况来处理。因此,在社区和三级医疗学术中心开发高效的基于医院的超急性卒中患者评估和干预方法至关重要。
我们描述了国立神经疾病与卒中研究所rt-PA卒中试验中的八个中心如何开发在症状发作3小时内纳入患者的系统。详细介绍了实际方法和实际事件顺序。应用了系统组织的戴明原则,每个中心都制定了急性卒中患者筛查、评估和治疗的流程图。我们将该过程分为以下几个方面:临床中心背景与准备、筛查、卒中团队响应、治疗前所需数据、头部CT、药房、患者治疗以及监测护理。总结了特定中心独有的以及几个中心共有的关键特征(四个或更多中心常见)。
试验的第一阶段包括几个月的准备工作,对每个站点急性卒中护理过程中涉及的每个细节进行审查。所有中心都与紧急医疗服务部门密切合作。开展了社区卒中意识和教育项目。启动了卒中团队,并与急诊科医生和护士密切合作。建立了快速高效的通信系统和协议,以减少完成每项任务的时间。使用了标准化的卒中检查以及血压管理和颅内出血检测协议以及护理流程图。
当卒中护理过程的各个方面都得到识别、简化并纳入院前和医院医疗服务系统的日常运营中时,在社区和学术环境中通常可以在患者到达医院后55分钟内开始超急性卒中治疗。